Screening

There is no screening for arginine vasopressin deficiency (AVP-D) or arginine vasopressin resistance (AVP-R) in the general population. Evidence of familial AVP-D or AVP-R should prompt consideration of focused genetic testing. AVP-neurophysin gene studies can be used for predictive screening in families with autosomal dominant familial AVP-D.[39]​ In patients with visual failure with optic atrophy and sensorineural deafness, consider WFS1 gene studies for Wolfram syndrome (also called DIDMOAD [diabetes insipidus, diabetes mellitus, optic atrophy, and deafness] syndrome).[41]

Following pituitary or para-pituitary surgery, assessment of pituitary function with the water deprivation test will establish the presence or absence of AVP-D.[3]

Use of this content is subject to our disclaimer